Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest astrocytoma Stories

2014-04-09 12:31:14

Three molecularly defined clusters could alter practice; 1 closely resembles deadly glioblastoma Comprehensive genomic analysis of low-grade brain tumors sorts them into three categories, one of which has the molecular hallmarks and shortened survival of glioblastoma multiforme, the most lethal of brain tumors, researchers reported at the American Association for Cancer Research Annual Meeting 2014. "The immediate clinical implication is that a group of patients with tumors previously...

2014-02-04 11:57:02

Largest-ever study of 20-year survival among pediatric low-grade glioma patients highlights radiation's association with higher mortality The first comprehensive, large-scale cohort study of the long-term survival of children treated for low-grade gliomas, the most common pediatric brain tumor, finds that almost 90 percent are alive 20 years later and that few die from the tumor as adults. However, children who received radiation as part of their treatment had significantly lower long-term...

2014-02-04 11:02:59

Presence of IDH1 mutation determines best treatment for malignant astrocytomas Astrocytomas are the most common malignant brain tumors. While most patients' tumors prove to be quite aggressive, outcomes overall can vary widely, with some patients surviving for many years. Now a new study has found that malignant astrocytoma patients whose tumors carry a specific genetic mutation benefit greatly from surgical removal of the largest possible amount of tumor. Preliminary results of the study...

2013-12-16 18:14:37

Rates of programmed cell death higher in mice treated with experimental drug than in untreated animals with same cancer An experimental drug that targets macrophages, a type of immune cells, in the microenvironment surrounding the lethal brain tumor glioblastoma multiforme decreased the cancer's growth and extended survival of laboratory mice with the cancer, scientists will report on Tuesday Dec. 17, at the American Society for Cell Biology (ASCB) annual meeting in New Orleans. The...

2013-11-26 16:24:43

HOUSTON, Nov. 26, 2013 /PRNewswire/ -- The Burzynski Clinic (BC) announced today the successful treatment of a child with recurrent diffuse intrinsic pontine gliosarcoma (DIPGGS) at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. Pediatric gliosarcoma (GS) is a rare variant of glioblastoma multiforme. The pontine location of this tumor is unusual, invariably fatal and successful treatment was not yet described in medical literature. The...

2013-11-26 16:24:41

HOUSTON, Nov. 26, 2013 /PRNewswire/ -- The Burzynski Clinic (BC) announced today that it has presented the results of a phase II study of antineoplastons A10 and AS2-1 (ANP) in children with recurrent high-grade glioma at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. There are no standard treatment recommendations for children with high-grade glioma after recurrence. New therapies are required for patients whose tumor recurs after...

2013-07-09 21:28:55

Brain cancer is the primary cause of cancer mortality in children. Even in cases when the cancer is cured, young patients suffer from the stress of a treatment that can be harmful to the developing brain. In a search for new target structures that would create more gentle treatments, cancer researchers are systematically analyzing all alterations in the genetic material of these tumors. This is the mission of the PedBrain consortium, which was launched in 2010. Led by Professor Stefan Pfister...

2013-03-26 12:30:06

-- Genomic, Molecular Findings by CHOP Researchers Will Help Inform Personalized Medicine -- PHILADELPHIA, March 26, 2013 /PRNewswire-USNewswire/ -- Pediatric researchers, investigating the biology of brain tumors in children, are finding that crucial differences in how the same gene is mutated may call for different treatments. A new study offers glimpses into how scientists will be using the ongoing flood of gene-sequencing data to customize treatments based on very specific mutations...

2013-03-22 23:04:18

Louis and Phyllis Jacobs Honored for Commitment to Brain Tumor Patients and the ABTA Chicago, IL (PRWEB) March 22, 2013 The American Brain Tumor Association (ABTA) has named Louis and Phyllis Jacobs as the recipients of the 2013 Joel A. Gingras, Jr. Award. For the past 14 years, the Jacobs have supported brain tumor patients and families in their community, as well as supported the ABTA´s brain tumor research funding initiatives. The Joel A. Gingras, Jr. Award is given annually to an...

2012-07-23 20:51:47

MDC and Charite researchers decipher the mechanism of action Neural precursor cells (NPC) in the young brain suppress certain brain tumors such as high-grade gliomas, especially glioblastoma (GBM), which are among the most common and most aggressive tumors. Now researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Charité — Universitätsmedizin Berlin have deciphered the underlying mechanism of action with which...